What You Should Know:
– Proprio has secured FDA clearance for Picasso, its fourth cleared capability within the Paradigm AI surgical platform.
– The feature enables “trace-based” optical registration, allowing spine surgeons to perform real-time, radiation-free 3D measurements of spinal alignment during surgery—addressing a critical gap where surgeons previously relied on static 2D X-rays or postoperative confirmation.
Radiation-Free “Digital Twins”
Legacy navigation systems often require “CBCT spins” or repeated X-rays that expose both patient and staff to cumulative radiation. Proprio’s Paradigm platform bypasses this using:
- Light-Field Imaging: Sensors capture directional light information to build a live “digital twin” of the patient’s anatomy.
- Trace-Based Registration (Picasso): Surgeons can now verify and refine anatomical registration optically at the point of care, eliminating the need to pause surgery for new CT scans.
- Real-Time 3D Characterization: Unlike 2D snapshots, this provides continuous measurements of spinal alignment and segmental angles as the procedure unfolds.
“Historically, spine surgeons have had limited ways to verify alignment during a procedure itself,” said Gabriel Jones, CEO and Co-Founder of Proprio. “As intraoperative measurement becomes more practical, surgeons are looking for tools that let them assess progress while they are operating, not after the fact. Picasso extends Paradigm’s existing 3D guidance capabilities by giving surgeons more direct control over registration at the point of care.”
